AI-generated summary
The authors compared intense pulsed light combined with low level light therapy against low level light therapy alone in one eye each of 24 people with meibomian gland dysfunction and dry eye disease, in a randomised paired-eye trial. Both treatments were associated with symptom frequency improvements, while only combined therapy improved symptom severity and tissue flavin fluorescence changes. The authors describe these as mechanistic changes that may warrant further study.
- Participants
- 24
- Who or what was studied
- Adults with meibomian gland dysfunction and dry eye disease
- Limits stated in the abstract
- The abstract describes a small trial with 24 participants and reports mechanistic changes that the authors frame as tentative ("may have").
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Purpose
To investigate ocular surface changes following intense pulsed light therapy (IPL) combined with low level light therapy (LLLT) versus LLLT alone for the treatment of meibomian gland dysfunction (MGD) in patients with dry eye disease (DED).
Methods
Twenty-four participants with MGD and DED were recruited into a double-masked, paired-eye clinical trial, with one eye randomised to being treated with combined therapy and the other eye with LLLT alone across 4 treatment sessions, each 2 to 3 weeks apart. Follow-up assessments were also conducted at 2 weeks and then 3 months after the final treatment. Outcome measures included change in DED signs, symptomatology and in-vivo confocal microscopy parameters at final follow-up from baseline. Mechanism of action was explored with laser doppler flowmetry and fluorescence measures of the central lower eyelid.
Results
Symptom frequency rated with the Symptom Assessment Questionnaire in Dry Eye improved from baseline to final follow-up with combined therapy (mean difference - 21.6; 95 % CI - 38.5, -4.8; p = 0.005) and LLLT alone (-20.5; 95 % CI - 37.9, -3.1; p = 0.01), while symptom severity improved only with combined therapy (-18.5; 95 % CI - 34.5, -2.6; p = 0.01). Both modalities improved meibum expressibility following 3 treatment sessions, although improvement remained at final follow-up only with LLLT alone (-0.5, 95 % CI - 0.8, -0.2; p < 0.001). Tissue flavin fluorescence decreased after the fifth visit only with combined therapy (-12.7; 95 % CI - 4.9, 20.6; p = 0.001).
Conclusions
Combined therapy may have further mechanistic changes in increasing cellular metabolism, in addition to improvements in symptoms and meibum expressibility compared to LLLT alone. LLLT alone could be considered an adjunctive therapy for MGD if IPL is contraindicated.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Dry eye, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.